Free Trial
NASDAQ:AADI

Aadi Bioscience (AADI) Stock Price, News & Analysis

Aadi Bioscience logo
$1.91 -0.06 (-3.05%)
As of 07/11/2025

About Aadi Bioscience Stock (NASDAQ:AADI)

Key Stats

Today's Range
$1.91
$1.99
50-Day Range
$1.58
$2.09
52-Week Range
$1.21
$3.81
Volume
129,531 shs
Average Volume
254,880 shs
Market Capitalization
$47.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.67
Consensus Rating
Hold

Company Overview

Aadi Bioscience Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
9th Percentile Overall Score

AADI MarketRank™: 

Aadi Bioscience scored higher than 9% of companies evaluated by MarketBeat, and ranked 900th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Aadi Bioscience has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 5 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Aadi Bioscience has received no research coverage in the past 90 days.

  • Read more about Aadi Bioscience's stock forecast and price target.
  • Earnings Growth

    Earnings for Aadi Bioscience are expected to grow in the coming year, from ($2.04) to ($0.94) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Aadi Bioscience is -0.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Aadi Bioscience is -0.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Aadi Bioscience has a P/B Ratio of 0.45. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Aadi Bioscience's valuation and earnings.
  • Short Interest

    There is no current short interest data available for AADI.
  • Dividend Yield

    Aadi Bioscience does not currently pay a dividend.

  • Dividend Growth

    Aadi Bioscience does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for AADI.
  • Search Interest

    3 people have searched for AADI on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Aadi Bioscience insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    37.30% of the stock of Aadi Bioscience is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    52.08% of the stock of Aadi Bioscience is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Aadi Bioscience's insider trading history.
Receive AADI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aadi Bioscience and its competitors with MarketBeat's FREE daily newsletter.

AADI Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More Headlines

AADI Stock Analysis - Frequently Asked Questions

Aadi Bioscience's stock was trading at $3.15 at the beginning of the year. Since then, AADI shares have decreased by 39.4% and is now trading at $1.91.

Aadi Bioscience, Inc. (NASDAQ:AADI) announced its earnings results on Tuesday, March, 18th. The company reported ($0.67) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.30) by $0.37. The business earned $7.24 million during the quarter, compared to analyst estimates of $7.45 million. Aadi Bioscience had a negative trailing twelve-month return on equity of 71.87% and a negative net margin of 246.06%.
Read the conference call transcript
.

Aadi Bioscience shares reverse split before market open on Friday, August 27th 2021.The 1-15 reverse split was announced on Thursday, August 26th 2021. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, August 25th 2021. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Shares of AADI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aadi Bioscience investors own include Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), JPMorgan Chase & Co. (JPM), Moderna (MRNA), NVIDIA (NVDA) and Alphabet (GOOG).

Company Calendar

Last Earnings
3/18/2025
Today
7/11/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:AADI
CIK
1422142
Fax
N/A
Employees
40
Year Founded
N/A

Price Target and Rating

High Price Target
$1.75
Low Price Target
$1.50
Potential Upside/Downside
-15.4%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.35)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$65.76 million
Net Margins
-246.06%
Pretax Margin
-246.06%
Return on Equity
-71.87%
Return on Assets
-57.28%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.89
Quick Ratio
4.54

Sales & Book Value

Annual Sales
$25.07 million
Price / Sales
1.94
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.29 per share
Price / Book
0.46

Miscellaneous

Outstanding Shares
24,697,000
Free Float
15,485,000
Market Cap
$48.65 million
Optionable
Optionable
Beta
0.68
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:AADI) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners